Zobrazeno 1 - 10
of 147
pro vyhledávání: '"Amresh, Raina"'
Autor:
Matthew Deicke, Laith Alhuneafat, Omar Obaid, Aderonke Adeniyi, Amresh Raina, Hayah Kassis‐George
Publikováno v:
Clinical Case Reports, Vol 10, Iss 12, Pp n/a-n/a (2022)
Abstract A 54‐year‐old man status post heart and kidney transplant presented with dyspnea. Imaging was consistent with lymphangitic carcinomatosis (LC), in the setting of biopsy proven adenocarcinoma. He developed pulmonary hypertension (PH) and
Externí odkaz:
https://doaj.org/article/88c3bc75dd2b4ca0969631306d35e737
Publikováno v:
Pulmonary Circulation, Vol 11, Iss 4, Pp 1-5 (2021)
There are limited data regarding the feasibility of transitioning from intravenous prostacyclins to selexipag in pulmonary arterial hypertension patients. We present a case series of successful transitions from intravenous prostacyclins to selexipag
Externí odkaz:
https://doaj.org/article/64c2238a361e404e8a5c02385f2a096e
Autor:
Kellie Morland, Amresh Raina, Abigail Nails, Peter Classi, Martine Etschmaier, Robert P. Frantz
Publikováno v:
Pulmonary Circulation, Vol 11, Iss 4, Pp 1-7 (2021)
While parenteral prostacyclin (pPCY) therapy, delivered either subcutaneously or intravenously, is recommended for pulmonary arterial hypertension patients with severe or rapidly developing disease, some patients refuse this treatment. This study aim
Externí odkaz:
https://doaj.org/article/9e917fc7fa4c40dd99ed2ca44e78afc3
Autor:
Aditya A. Joshi, Raef H. Hajjali, Avantee V. Gokhale, Triston Smith, Amit K. Dey, Garima Dahiya, Joseph B. Lerman, Aparna P. Sajja, Manreet Kanwar, Amresh Raina
Publikováno v:
Pulmonary Circulation, Vol 11 (2021)
Pulmonary embolism (PE) is a major cause of cardiovascular morbidity and mortality. Obstructive sleep apnea (OSA) is increasingly recognized in the aging population, especially with the rising obesity epidemic. The impact of OSA on inpatient mortalit
Externí odkaz:
https://doaj.org/article/3add1f9875de4f5b9696b821f885c3b3
Publikováno v:
Pulmonary Circulation, Vol 10 (2020)
The combination of bosentan and sildenafil is commonly used to treat patients with pulmonary arterial hypertension (PAH); however, there is evidence of a significant drug interaction between these two medications. We sought to evaluate the safety and
Externí odkaz:
https://doaj.org/article/0cab27788e5047cc8fe8b7a450e5f4d8
Autor:
Abhishek Chaturvedi, Manreet Kanwar, Parul Chandrika, Thenappan Thenappan, Amresh Raina, Raymond L Benza
Publikováno v:
Data in Brief, Vol 32, Iss , Pp 106303- (2020)
A comprehensive description of the contemporary trends in pulmonary arterial hypertension (PAH) related hospitalizations, associated inpatient outcomes and predictors of worse outcomes were reported in our paper recently published in the Internationa
Externí odkaz:
https://doaj.org/article/847e6717fb9f43dfaa651cdae312ad7c
Autor:
Raymond L. Benza, Paul A. Corris, Hossein-Ardeschir Ghofrani, Manreet Kanwar, Vallerie V. McLaughlin, Amresh Raina, Gérald Simonneau
Publikováno v:
Pulmonary Circulation, Vol 10 (2020)
Currently, five classes of drug are approved for the treatment of pulmonary arterial hypertension (PAH): phosphodiesterase 5 inhibitors (PDE5i); endothelin receptor antagonists; prostacyclin analogs; the IP receptor agonist selexipag; and the soluble
Externí odkaz:
https://doaj.org/article/443ec42f177c4b7d9487ebf8c4e839f1
Autor:
Amresh Raina, Marc Humbert
Publikováno v:
European Respiratory Review, Vol 25, Iss 142, Pp 390-398 (2016)
Regular patient assessment is essential for the management of chronic diseases, such as pulmonary arterial hypertension (PAH). Comprehensive patient assessment and risk stratification in PAH are important to guide treatment decisions and to monitor d
Externí odkaz:
https://doaj.org/article/8e11506e25034c2d93dd63c76b29b365
Publikováno v:
Pulmonary Circulation, Vol 8 (2018)
To assess the relationship of cytokines with functional and clinical outcomes in pulmonary arterial hypertension (PAH). Endothelial dysfunction and vascular inflammation are characteristic of PAH. We investigated whether markers of angiogenesis and i
Externí odkaz:
https://doaj.org/article/01059f71940d4f13a5f8f3c1337e873d
Autor:
Raymond L. Benza, Amresh Raina, Himanshu Gupta, Srinivas Murali, Annie Burden, Michael S. Zastrow, Myung H. Park, Marc A. Simon
Publikováno v:
Pulmonary Circulation, Vol 8 (2018)
The phase 4 COMPASS-3 study evaluated whether a singular endpoint produces clinically meaningful outcomes in patients with pulmonary arterial hypertension (PAH). The relationship between cardiac magnetic resonance imaging (cMRI)-derived parameters an
Externí odkaz:
https://doaj.org/article/bda6356472b94e9e8af5f986d7c08d3b